Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in X-linked Hypophosphatemic Rickets (XLH)
NCT00417612Phase 3Completed
- Sponsor
- Yale University
- Start
- Jan 2007
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of paricalcitol in X-linked hypophosphatemic rickets (XLH), sponsored by Yale University. Started Jan 2007; status: completed.
02
Drugs
paricalcitol
03
Conditions
X-linked hypophosphatemic rickets (XLH)
Beyond the preview
Go deeper on NCT00417612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417612.